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Dear Editor,  
Frailty is recognized as a state of age-related decreased resistance and increased vulnerability to 
adverse outcomes.1-3 An increase in recently conducted research on frailty has added mounting 
evidence to the literature. However, most of the studies focused on non-institutionalized 
populations and only limited evidence among nursing home (NH) populations exists. As 
expected, most of the NH patients are very frail.4 Another common condition among NH 
populations is vitamin D deficiency.5 A number of studies have shown associations of vitamin D 
deficiency with a wide range of skeletal and non-skeletal medical conditions,6 all of which may 
contribute to the development of frailty. This study aimed to investigate the association between 
frailty and vitamin D status among NH patients, which, to our knowledge, has not been 
examined. 
 
METHODS 
This is a cross-sectional study performed on all male veterans admitted to a NH in 2011-2012.5 
Patient demographic information collected on NH admission included age, body mass index 
(BMI), ethnicity, education, smoking, alcohol use, place where patients came from, reason for 
admission, prevalent chronic diseases, serum total 25-hydroxyvitamin D (25(OH)D) level, 
vitamin D supplementation use, and Activities of Daily Living (ADL). Frailty was measured by 
using Frailty Index (FI) constructed from 34 deficits. Frailty was defined as FI>=0.25.7 Vitamin 
D deficiency was defined as 25(OH)D<20 ng/mL.6 
 
Baseline characteristics were compared between frail and non-frail groups using t-tests and 
chi-square tests. Univariate and multivariate logistic regression models examined associations 
between frailty and vitamin D status. 
 
RESULTS 
Of 302 male patients admitted to the NH, those without 25(OH)D measured within seven days of 
admission, with more than 30% of deficit variables missing, or on vitamin D supplementation 
were excluded, leaving 152 patients. Mean age was 70.3 years, and the majority of the patients 
were either White (50.0%) or Asian/Pacific Islander (40.1%). Mean FI was 0.37 ranging 
0.04-0.63. Prevalence of frailty was 81.6%. Frail patients were significantly older (71.9 vs. 62.8 
years) and more likely to be vitamin D deficient (50.0% vs. 28.6%) with lower 25(OH)D levels 
(20.8 vs. 24.7 ng/mL). (Table) 
 
Univariate logistic regression models showed frailty was significantly associated with vitamin D 
deficiency (OR=2.50, p=0.04) and lower 25(OH)D (OR=0.96 per 1 ng/mL increase, p=0.05). 
Multivariate logistic regression models adjusted for age, ethnicity, and education showed both 
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vitamin D deficiency (OR=4.06 , p=0.01) and lower 25(OH)D (OR=0.95 per 1ng/mL increase, 
p=0.05) were significantly associated with frailty. 
 
DISCUSSION 
There has been plausible evidence that supports physiological pathways through which low 
vitamin D status increases risk of frailty. Low vitamin D levels are associated with poor physical 
performance2,8 and symptoms of depression.9 Vitamin D has also been found to be involved in 
inflammatory processes.10 All of these may contribute to developing and worsening frailty. 
 
Our results should be interpreted with caution. The findings may not be generalizable due to the 
relatively small cohort consisting of only male veterans. Approximately half of patients were 
excluded due to vitamin D supplement use (n=109, 36.1%) and 25(OH)D not measured  within 
7 days of admission (n=61, 20.2%). Excluded patients were older (76.4 vs. 70.3 years, p<0.001), 
had more ADL disabilities (4.0 vs. 3.1, p<0.001), higher FI (0.42 vs. 0.37, p=0.003), and higher 
BMI (27.3 vs. 25.1, p=0.005). We also lack data regarding sunlight exposure, which may affect 
serum 25(OH)D levels. Lastly causal relationship cannot be inferred because of the 
cross-sectional study design. 
 
However, this study has many strengths. First, this is the first study to report on the associations 
between frailty and vitamin D among NH patients. Second, this study is especially valuable in 
that the data were collected at the time of NH admission, not at a certain point during NH stay as 
in most studies. Third, we excluded vitamin D supplement users to reduced bias. The supplement 
users (n=109) were significantly older (mean age=77.9 vs. 70.3 years old, p<0.001) and frailer 
(mean Frailty Index=0.42 vs. 0.37, p=0.003), but had higher mean 25(OH)D level (27.1 ng/mL 
vs. 21.5 ng/mL, p<0.001). This suggests older frailer NH patients may have already been started 
on supplementation and thus had higher vitamin D levels. Furthermore, the dosage of the 
supplementation varied greatly from 400 IU daily to as high as 50,000 IU weekly. Vitamin D 
supplementation would, if not controlled for, significantly confound the results and lead to 
misinterpretation. 
 
This study showed the prevalence of frailty was high at 81.6%, and lower vitamin D status was 
significantly associated with frailty among NH patients. Vitamin D supplementation may 
potentially be an inexpensive and well-tolerated intervention to prevent or reverse frailty. 
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FIGURE 
Table. Baseline Characteristics of Participants by Frailty Status (N=152) 
  Frailty Status  
n (%) or mean + SD 
Entire Cohort 
(N=152) 
Non-frail 
(N=28) 
Frail 
(N=124) 
p-value 
Frailty Index 0.37+0.14 0.17+0.04 0.42+011 <0.001 
Age (years) 70.3+12.8 62.8+8.6 71.9+13.1 <0.001 
Body mass index (kg/m2) 27.3+6.9 26.7+4.90 27.43+7.33 0.50 
Education (years) 13.0+2.3 13.3+2.3 13.0+2.3 0.50 
Ethnicity     
 White 76 (50.0%) 18 (64.3%) 58 (46.8%) 0.19 
 Asian/Pacific islander 61 (40.1%) 9 (32.1%) 52 (41.9%)  
 Others 15 (9.9%) 1 (3.6%) 14 (11.3%)  
Reason for admission     
 Rehabilitation 60 (39.5%) 11 (39.3%) 49 (39.5%) - 
 Skilled-nursing care 42 (27.6%) 17 (60.7%) 25 (20.2%)  
 Intermediate care 4 (2.6%) 0 (0.0%) 4 (3.2%)  
 Respite 46 (30.3%) 0 (0.0%) 46 (37.1%)  
Place patients came from     
 Home 47 (30.9%) 0 (0.0%) 47 (37.9%) - 
 Acute care 100 (65.8%) 28 (100.0%) 72 (58.1%)  
 other nursing home 5 (3.3%) 0 (0.0%) 5 (4.0%)  
Smoking     
 never 53 (34.9%) 10 (35.7%) 43 (34.7%) 0.87 
 past 71 (46.7%) 12 (42.9%) 59 (47.6%)  
 current 28 (18.4%) 6 (21.4%) 22 (17.7%)  
Alcohol     
 never 61 (40.1%) 11 (39.3%) 50 (40.3%) 0.88 
 past 53 (34.9%) 9 (32.1%) 44 (35.5%)  
 current 38 (25.0%) 8 (28.6%) 30 (24.2%)  
25(OH)D (ng/mL) 21.5+9.6 24.7+8.4 20.8+9.7 0.05 
Vitamin D deficiency 70 (46.1%) 8 (28.6%) 62 (50.0%) 0.04 
T-tests used for continuous variables, chi-square tests used for categorical variables. 
